loadpatents
Patent applications and USPTO patent grants for Ahmed; Nabil M..The latest application filed is for "universal immune cells for cancer immunotherapy".
Patent | Date |
---|---|
Platform for enhanced targeted delivery Grant 11,376,332 - Ahmed , et al. July 5, 2 | 2022-07-05 |
Universal Immune Cells For Cancer Immunotherapy App 20220125847 - Ahmed; Nabil M. ;   et al. | 2022-04-28 |
Universal immune cells for cancer immunotherapy Grant 11,219,644 - Ahmed , et al. January 11, 2 | 2022-01-11 |
Platform For Enhanced Targeted Delivery App 20190240343 - Ahmed; Nabil M. ;   et al. | 2019-08-08 |
Universal Immune Cells For Cancer Immunotherapy App 20180085399 - Ahmed; Nabil M. ;   et al. | 2018-03-29 |
HER2/ErbB2 Chimeric Antigen Receptor App 20180079824 - Ahmed; Nabil M. ;   et al. | 2018-03-22 |
Immunotherapy Of Cancer Using Genetically Engineered Gd2-specific T Cells App 20170027988 - Brenner; Malcolm ;   et al. | 2017-02-02 |
Chimeric Antigen Receptor For Bispecific Activation And Targeting Of T Lymphocytes App 20160303230 - Ahmed; Nabil M. ;   et al. | 2016-10-20 |
Vascular-targeted T-cell Therapy App 20160015750 - Gottschalk; Stephen M. G. ;   et al. | 2016-01-21 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.